Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo

 

Get News and Updates

 

eco

CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn

ny

New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Monthly Archives: June 2012

PeriRx Developing Cancer Tool for Dentists

PeriRx887HAVERTOWN — A personalized medicine company is out to make a trip to the dentist more meaningful than simply a checkup for cavities and a teeth cleaning.

PeriRx has licensed and is completing the development of a non-invasive saliva test for dentists that can be used to detect and predict oral cancer — the world’s sixth most common cancer.

Stephen M. Swanick, CEO of PeriRx, said the 4-year-old Delaware County company is in discussions with several large pharmaceutical companies, including GlaxoSm-thKline and Johnson & Johnson, about teaming up on the distribution of its molecular diagnostic test for oral cancer and a second product targeted the early diagnosis of diabetes. [Read more…]